It's not a New Year's Eve party without our favourite tipple in hand to toast the next 12 months in - and decades past saw us ...

H.C. Wainwright initiated coverage of Terra Innovatum ( NKLR) with a Buy rating and $25 price target. The firm believes the company’s use of off-the-shelf components with established supply chains ...

For 47 years, Food & Wine has predicted where American dining is headed. Here’s a look at trend calls that shaped how we eat ...

Correspondence to Dr Kathrin S Michelsen, F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; kathrin.michelsen{at}cshs.org; Professor Dermot P ...

When shopping for a high-quality used car or SUV, who wouldn’t be against a vehicle with a luxury badge that’s loaded with ...

– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Sitala Bio Ltd. has divulged complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, schizophrenia, atypical hemolytic uremic syndrome, ...

The complement system, consisting of three initiating pathways—classical, lectin and alternative, is an important part of innate immunity. Dysregulation of the complement system is implicated in the ...

This important work advances our understanding of factors influencing efficacy assessments and biomarker viability for complement-directed gene therapy against age-related macular degeneration. The ...